Filing Flows › Envoy Medical (COCH) › Q3 2026 › vs Q2 2026
Envoy Medical (COCH) Q3 2026 vs Q2 2026 (quarter over quarter)
Envoy Medical's revenue rose $15K (+29%) from $51K in Q2 2026 to $66K in Q3 2026.
Envoy Medical, Q3 2026: revenue $66K (+57% year over year), net loss $3.9M, operating cash flow −$5.0M. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $66K | $51K | $15K | +29% |
| Other income, net | $1.6M | −$413K | $2.0M | — |
| Net loss | $3.9M | $6.0M | −$2.0M | -34% |
| Costs & expenses | $5.6M | $6.0M | −$430K | -7% |
| Operating costs | $5.6M | $5.6M | −$17K | -0.3% |
| Cost of revenue | $244K | $278K | −$34K | -12% |
| Research & development | $3.1M | $3.1M | −$55K | -2% |
| Sales & marketing | $157K | $181K | −$24K | -13% |
| General & admin | $2.1M | $2.0M | $96K | +5% |
| Operating cash sources | $5.4M | $5.7M | −$332K | -6% |
| Depreciation | $75K | $74K | $1K | +1% |
| Share-based compensation | $307K | $214K | $93K | +43% |
| Cash used in operations | $5.0M | $5.5M | −$426K | -8% |
| Net loss absorbed | $3.9M | $6.0M | −$2.0M | -34% |
| Working capital & other | $1.5M | −$238K | $1.7M | — |
Questions
How much did Envoy Medical's revenue grow quarter over quarter in Q3 2026?
Envoy Medical's revenue rose $15K (+29%) from $51K in Q2 2026 to $66K in Q3 2026.